129 related articles for article (PubMed ID: 18954721)
1. Comment on "Magical protons?" editorial by Goitein (Int J Radiat Oncol Biol Phys 2008;70:654-656).
Fowler JF
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1270-1. PubMed ID: 18954721
[No Abstract] [Full Text] [Related]
2. Comment on editorial "Magical protons" by Dr. Michael Goitein (Int J Radiat Oncol Biol Phys 2008;70:654-656) and in reply to Dr. Fowler.
Withers HR; Peters LJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1271. PubMed ID: 18954723
[No Abstract] [Full Text] [Related]
3. Magical protons?
Goitein M
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):654-6. PubMed ID: 18262083
[No Abstract] [Full Text] [Related]
4. Neutron dose in proton radiation therapy: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7).
Paganetti H; Bortfeld T; Delaney TF
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1594-5; author reply 1595. PubMed ID: 17126219
[No Abstract] [Full Text] [Related]
5. In regards to Hall: intensity-modulated radiation therapy, protons, and the risk of second cancers (Int J Radiat Oncol Biol Phys 2006;65:1-7).
Macklis R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1593-4; author reply 1595. PubMed ID: 17126216
[No Abstract] [Full Text] [Related]
6. Neutron dose in scattered and scanned proton beams: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7).
Gottschalk B
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1594; author reply 1595. PubMed ID: 17126218
[No Abstract] [Full Text] [Related]
7. In regards to Dr. Eisbruch A et al. (Int J Radiat Oncol Biol Phys 2009. Electronic publication, June 17, 2009.).
Ibbott GS; Molineu A; Followill DS
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):639; author reply 639. PubMed ID: 20117298
[No Abstract] [Full Text] [Related]
8. Comment on Drs. Withers and Peters' letter concerning the editorial "magical protons?".
Goitein M
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):957-8; author reply 958. PubMed ID: 20159368
[No Abstract] [Full Text] [Related]
9. Conformity index (CI) and radiation treatment of lung cancer: in regards to Chang et al. (Int J Radiat Oncol Biol Phys 2006;65:1087-1096).
Armstrong JG
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1272; author reply 1272. PubMed ID: 17637400
[No Abstract] [Full Text] [Related]
10. Integrated prostate cancer centers and over-utilization of IMRT: In regard to Falit et al. (Int J Radiat Oncol Biol Phys 2010;76:1285-1288).
Rickles DJ
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1280; author reply 1280-1. PubMed ID: 21353167
[No Abstract] [Full Text] [Related]
11. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
Albertini F; Lomax AJ; Hug EB
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
[No Abstract] [Full Text] [Related]
12. Dose-rate effects when estimating risks for second malignancies: in regard to Fontenot et al (Int J Radiat Oncol Biol Phys 2009;74:616-622).
Paganetti H; Athar BS; Bednarz B
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1624; author reply 1624-5. PubMed ID: 19931743
[No Abstract] [Full Text] [Related]
13. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy: In regard to Lee et al. (Int J Radiat Oncol Biol Phys 2006;64:301-320).
Dai J; Hu Y
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1594-5. PubMed ID: 16863939
[No Abstract] [Full Text] [Related]
14. Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296).
Wolmark N; Curran WJ; Vicini F; White J; Costantino JP; Arthur D; Kuske R; Rabinovitch R; Julian TB; Parda DS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):317; author reply 318. PubMed ID: 20394863
[No Abstract] [Full Text] [Related]
15. Calculated risk of fatal secondary malignancies from intensity-modulated radiotherapy: In regard to Kry et al. (Int J Radiat Oncol Biol Phys 2005;62:1195-1203).
Schneider U
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1290; author reply 1290-1. PubMed ID: 16504771
[No Abstract] [Full Text] [Related]
16. In regards to Dennis and Duncan: Radiation oncology in undergraduate medical education: a literature review (Int J Radiat Oncol Biol Phys 2010;76:649-655).
Hirsch AE; DeNunzio N; Levin-Epstein R; Bishop PM
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):639; author reply 639. PubMed ID: 20832670
[No Abstract] [Full Text] [Related]
17. Response to "Integrated prostate cancer centers and overutilization of IMRT: a close look at fee-for-service medicine in radiation oncology." (Int J Radiat Oncol Biol Phys 2010;78:1285-1288).
Zimberg SH; Olsson CA
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1607; author reply 1607-8. PubMed ID: 21092840
[No Abstract] [Full Text] [Related]
18. In regards to Glatstein: the whirligig of time (Int J Radiat Oncol Biol Phys 2006;65:322-323).
Tewfik HH
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):630. PubMed ID: 16966006
[No Abstract] [Full Text] [Related]
19. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022.
Bongers EM; Dahele MR; Slotman BJ; Senan S; Bot JC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):492; author reply 492. PubMed ID: 22182718
[No Abstract] [Full Text] [Related]
20. Dueling Technologies: in regard to Ling et al. (Int J Radiat Oncol Biol Phys 2008;72:575-581).
Mohan R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):6-7; discussion 8-9. PubMed ID: 19695433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
